386 related articles for article (PubMed ID: 29347917)
1. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
Cheon S; Park HJ; Chae Y; Lee H
BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
[TBL] [Abstract][Full Text] [Related]
2. Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers.
Cousins S; Huttman M; Blencowe N; Tsang C; Elliott D; Blazeby J; Beard DJ; Campbell MK; Gillies K
Trials; 2024 May; 25(1):339. PubMed ID: 38778336
[TBL] [Abstract][Full Text] [Related]
3. Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?
Feys F; Bekkering GE; Singh K; Devroey D
Syst Rev; 2014 Feb; 3():14. PubMed ID: 24555576
[TBL] [Abstract][Full Text] [Related]
4. Drug trials are more likely to disclose full placebo control information than non-drug trials: A cross-sectional study of participant information leaflets of placebo-controlled trials.
Won J; Han JY; Ji YJ; Ha D; Han BJ; Lee H
Integr Med Res; 2024 Jun; 13(2):101043. PubMed ID: 38779540
[TBL] [Abstract][Full Text] [Related]
5. Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos.
Bishop FL; Adams AE; Kaptchuk TJ; Lewith GT
PLoS One; 2012; 7(6):e39661. PubMed ID: 22761859
[TBL] [Abstract][Full Text] [Related]
6. How informed is consent in sham-controlled trials of acupuncture?
Linde K; Dincer F
J Altern Complement Med; 2004 Apr; 10(2):379-85. PubMed ID: 15165419
[TBL] [Abstract][Full Text] [Related]
7. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
Murphy E; Gillies K; Shiely F
Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790
[TBL] [Abstract][Full Text] [Related]
8. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
Trials; 2014 Feb; 15():62. PubMed ID: 24548781
[TBL] [Abstract][Full Text] [Related]
9. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
Cuddihy L; Howick J; Murphy E; Shiely F
Trials; 2024 May; 25(1):292. PubMed ID: 38693579
[TBL] [Abstract][Full Text] [Related]
10. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials.
Kirby N; Shepherd V; Howick J; Betteridge S; Hood K
Trials; 2020 Jul; 21(1):658. PubMed ID: 32680561
[TBL] [Abstract][Full Text] [Related]
11. Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial.
Djavadkhani Y; Marshall NS; D'Rozario AL; Crawford MR; Yee BJ; Grunstein RR; Phillips CL
Thorax; 2015 Mar; 70(3):265-9. PubMed ID: 25595508
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture trials and informed consent.
Miller FG; Kaptchuk TJ
J Med Ethics; 2007 Jan; 33(1):43-4. PubMed ID: 17209110
[TBL] [Abstract][Full Text] [Related]
13. Trial participants' self-reported understanding of randomisation phrases in participation information leaflets can be high, but acceptability of some descriptions is low, especially those linked to gambling and luck.
Shiely F; Murphy E; Gilles K; Hood K; O'Sullivan L; Harman N; Isaacs T; Treweek S
Trials; 2024 Jun; 25(1):391. PubMed ID: 38890748
[TBL] [Abstract][Full Text] [Related]
14. Relative importance of informational items in participant information leaflets for trials: a Q-methodology approach.
Innes K; Cotton S; Campbell MK; Elliott J; Gillies K
BMJ Open; 2018 Sep; 8(9):e023303. PubMed ID: 30185580
[TBL] [Abstract][Full Text] [Related]
15. Audio-visual presentation of information for informed consent for participation in clinical trials.
Ryan RE; Prictor MJ; McLaughlin KJ; Hill SJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD003717. PubMed ID: 18254029
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the management of dry mouth: non-pharmacological interventions.
Furness S; Bryan G; McMillan R; Worthington HV
Cochrane Database Syst Rev; 2013 Aug; (8):CD009603. PubMed ID: 23996155
[TBL] [Abstract][Full Text] [Related]
17. Acupuncture for the Prevention of Tension-Type Headache (2016).
Nielsen A
Explore (NY); 2017; 13(3):228-231. PubMed ID: 28392178
[TBL] [Abstract][Full Text] [Related]
18. Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design.
Hammami MM; Hammami S; Al-Swayeh R; Al-Gaai E; Farah FA; De Padua SJ
BMC Med Res Methodol; 2016 Nov; 16(1):166. PubMed ID: 27899067
[TBL] [Abstract][Full Text] [Related]
19. Participants' experiences of being debriefed to placebo allocation in a clinical trial.
Bishop FL; Jacobson EE; Shaw J; Kaptchuk TJ
Qual Health Res; 2012 Aug; 22(8):1138-49. PubMed ID: 22673094
[TBL] [Abstract][Full Text] [Related]
20. Implications of the 'placebo effect' for CAM research.
Relton C
Complement Ther Med; 2013 Apr; 21(2):121-4. PubMed ID: 23497816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
